Therapy in patients at high risk for atherosclerotic cardiovascular disease -: From biological efficacy to disappointing clinical outcomes

被引：0
|
作者：
Fainaru, M [1 ]
机构：
[1] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel
来源：
FREE RADICAL BIOLOGY AND MEDICINE | 2002年 / 33卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
487
引用
收藏
页码：S186 / S186
页数：1
相关论文
共 50 条
  • [21] Effect of evacetrapib on cardiovascular outcomes in patients with high-risk cardiovascular disease
    Aronow, Wilbert S.
    JOURNAL OF THORACIC DISEASE, 2017, 9 (07) : 1822 - 1825
  • [22] Antithrombotic Therapy for Atherosclerotic Cardiovascular Disease Risk Mitigation in Patients With Coronary Artery Disease and Diabetes Mellitus
    Capodanno, Davide
    Angiolillo, Dominick J.
    CIRCULATION, 2020, 142 (22) : 2172 - 2188
  • [23] PREDICTING THE EFFICACY OF INCLISIRAN ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH ESTABLISHED ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: PRIMARY RESULTS OF THE IN SILICO SIRIUS TRIAL
    Angoulvant, Denis
    Amarenco, Pierre
    Bastien, Alexandre
    Bechet, Emmanuelle
    Boccara, Franck
    Boissel, Jean-Pierre
    Cariou, Bertrand
    Courcelles, Eulalie
    Diatchenko, Alizee
    Filipovics, Anne
    Granjeon-Noriot, Solene
    Kahoul, Riad
    Mahe, Guillaume
    Peyronnet, Emmanuel
    Portal, Lolita
    Porte, Solene
    Wang, Yishu
    Steg, Philippe Gabriel
    ATHEROSCLEROSIS, 2024, 395
  • [24] Simulation of lipid-lowering therapy (LLT) intensification in very high-risk patients with atherosclerotic cardiovascular disease
    Gu, Jing
    Sanchez, Robert J.
    Chauhan, Ankita
    Fazio, Sergio
    Rosenson, Robert S.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2022, 16 (06) : 901 - 905
  • [25] Predicted efficacy of Inclisiran compared to active comparators on Cardiovascular Outcomes in patients with established atherosclerotic cardiovascular disease: results from the In Silico SIRIUS trial
    Cariou, Bertrand
    Angoulvant, Denis
    Amarenco, Pierre
    Bastien, Alexandre
    Bechet, Emmanuelle
    Boissel, Jean-Pierre
    Courcelles, Eulalie
    Filipovics, Anne
    Granjeon-Noriot, Solene
    Kahoul, Riad
    Mahe, Guillaume
    Peyronnet, Emmanuel
    Portal, Lolita
    Wang, Yishu
    Steg, Philippe
    Boccara, Franck
    CIRCULATION, 2024, 150
  • [26] Risk of Atherosclerotic Cardiovascular Disease in Patients With Bipolar Disorder and Accuracy of a Cardiovascular Risk Calculator
    Foroughi, Moein
    Medina-Inojosa, Jose R.
    Lopez-Jimenez, Francisco
    Saeidifard, Farzane
    Viniciguerra, Manlio
    Frye, Mark A.
    Morgan, Robert J.
    BIOLOGICAL PSYCHIATRY, 2018, 83 (09) : S283 - S283
  • [27] Cancer patients receiving immune checkpoint inhibitor therapy are at an increased risk for atherosclerotic cardiovascular disease
    Lutgens, Esther
    Seijkens, Tom T. P.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
  • [28] ASSOCIATIONS BETWEEN BETA-BLOCKER THERAPY AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH DIABETES AND ESTABLISHED ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: INSIGHTS FROM THE TECOS STUDY
    Shavadia, Jay
    Zheng, Yinggan
    Green, Jennifer B.
    Armstrong, Paul
    Westerhout, Cynthia
    McGuire, Darren
    Roe, Matthew
    Cornel, J. H.
    Holman, Rury
    Peterson, Eric D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 138 - 138
  • [29] QUANTITATIVE PLAQUE STAGING SYSTEM PREDICTS LONG-TERM CARDIOVASCULAR OUTCOMES IN PATIENTS AT RISK FOR ATHEROSCLEROTIC CARDIOVASCULAR DISEASE
    Nurmohamed, Nick S.
    Bom, Michiel
    Jukema, Ruurt
    De Groot, Robin
    Driessen, Roel
    Van Diemen, Pepijn
    Sprengers, Ralf
    Min, James K.
    Earls, James P.
    Danad, Ibrahim
    Choi, Andrew D.
    Knaapen, Paul
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 1153 - 1153
  • [30] Possible clinical usefulness of polygenic risk scores among patients with established atherosclerotic cardiovascular disease
    Tamura, Kouichi
    Kumagai, Tomohiro
    Kobayashi, Kazuo
    ATHEROSCLEROSIS, 2022, 350 : 100 - 101
12345